IRB Submissions Reviews and Approvals

Speaker

Instructor: John E Lincoln
Product ID: 706992
Training Level: Intermediate to Advanced

Location
  • 5
  • November 2024
    Tuesday
  • 10:00 AM PT | 01:00 PM ET
    Duration: 90 Min
To establish that a drug or device is safe and effective, tests are required. There are many preliminary tests, including lab tests, standards, guidances, etc. Finally the product must be tried out on humans / patients in a tightly controlled environment. The clinical site(s) IRB Review is and FDA requirement and crucial to obtaining a site(s).
LIVE ONLINE TRAINING

November 05, Tuesday 10:00 AM PT | 01:00 PM ET
Duration: 90 Min

 

$199.00
One Dial-in One Attendee

$899.00
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

$379.00

$449.00

$249.00
1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training
(For multiple locations contact Customer Care)

$349.00
Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days after completion of Live training
(For multiple locations contact Customer Care)

 

 

Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

 

Description:

Clinical trials are research studies in which people volunteer to help find answers to specific health questions. To initiate they require IRB review and approval. Then, when carefully conducted, they are the safest and fastest way to find new treatments and ways to improve health.

Clinical trials are conducted according to a plan, called a protocol, reviewed / approved by the IRB, which describes:

  • The types of patients who may enter the study;
  • The schedules of tests and procedures;
  • The drug involved;
  • The dosages, or amount of the drug used by patient;
  • The length of the study; and
  • What the researchers (sponsor) hope to learn from the study.

All such trials are to be conducted under strict rules, such as FDA and ICH requirements, and the specific IRB's requirements.

Why Should You Attend:

This webinar will focus on the US FDA and ICH regulatory requirements for IRB approval for clinical trials on humans. The requirements further ensure that there are rules and terms outlined and mutually agreed to in the IRB submission with the protocol outline, to result in valid data to be used to evaluate the subjects in the trial. Participants and the researchers, doctors and health practitioners all must agree to the terms of the study as outlined in the protocol. All must understand the risks involved. Safety to the human subjects is stressed. The professionals who manage and administer the trials must follow the strict regulatory rules for clinical trials set by the government agencies and outlined in the IRB submission. These rules make sure that those who agree to participate are treated as safely as possible, and that the outcomes are scientifically arrived at.

Areas Covered in the Webinar:

  • Clinical trial basics

  • Participant safety issues
  • FDA's Guidance for IRBs and ICH E6, et al

  • IRB Submissions. Reviews and Approvals

  • Documentation requirements: Before, during, and after
  • Trial administration
  • Key steps in the IRB submission and review process
  • Deliverable Formats
  • Subject safety

Who Will Benefit:

  • Marketing
  • Senior management
  • Regulatory Affairs
  • Quality Assurance
  • Production
  • R&D and Engineering
  • All personnel involved in EU Clinical Trials, especially those involved in new product (mainly drug) development, and changes, as to the need for clinical trials held in the EU.
Instructor Profile:
John E Lincoln

John E Lincoln
Principal, J E Lincoln and Associates

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 42 years experience in U.S. FDA-regulated industries, 27 of which are as an independent consultant. John has worked with global companies to resolve regulatory issues, lead validations (hardware and software) and implement QMS/RA systems. He has published numerous articles in peer reviewed journals, 5 chapters in the RAPS textbook on Validation, conducted workshops and webinars worldwide. John is a graduate of UCLA.

Follow us :

 

 

Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).

 

 

+1-888-717-2436

6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube

 

Copyright © 2023 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method